A key event in the carcinogenesis of GIST is the acquisition of gain-of-function mutations in the genes encoding the receptor tyrosine kinase KIT (80-90%) or platelet derived growth factor receptor α (PDGFRA) (5-10%) [1]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.